- Home
- CLFD vs VERV Comparison
CLFD vs VERV Comparison
Compare CLFD & VERV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CLFD
- VERV
- Stock Information
- Founded
- CLFD 1979
- VERV 2018
- Country
- CLFD United States
- VERV United States
- Employees
- CLFD N/A
- VERV N/A
- Industry
- CLFD Telecommunications Equipment
- VERV Medicinal Chemicals and Botanical Products
- Sector
- CLFD Utilities
- VERV Health Care
- Exchange
- CLFD Nasdaq
- VERV Nasdaq
- Market Cap
- CLFD 468.1M
- VERV 475.0M
- IPO Year
- CLFD N/A
- VERV 2021
- Fundamental
- Price
- CLFD $29.90
- VERV $5.22
- Analyst Decision
- CLFD Strong Buy
- VERV Strong Buy
- Analyst Count
- CLFD 3
- VERV 5
- Target Price
- CLFD $46.67
- VERV $25.50
- AVG Volume (30 Days)
- CLFD 124.5K
- VERV 1.3M
- Earning Date
- CLFD 05-01-2025
- VERV 05-07-2025
- Dividend Yield
- CLFD N/A
- VERV N/A
- EPS Growth
- CLFD N/A
- VERV N/A
- EPS
- CLFD N/A
- VERV N/A
- Revenue
- CLFD $167,951,000.00
- VERV $32,332,000.00
- Revenue This Year
- CLFD $8.64
- VERV N/A
- Revenue Next Year
- CLFD $16.53
- VERV N/A
- P/E Ratio
- CLFD N/A
- VERV N/A
- Revenue Growth
- CLFD N/A
- VERV 174.98
- 52 Week Low
- CLFD $26.94
- VERV $4.31
- 52 Week High
- CLFD $44.83
- VERV $13.24
- Technical
- Relative Strength Index (RSI)
- CLFD 45.90
- VERV 35.67
- Support Level
- CLFD $27.65
- VERV $5.26
- Resistance Level
- CLFD $32.57
- VERV $5.99
- Average True Range (ATR)
- CLFD 1.01
- VERV 0.45
- MACD
- CLFD 0.28
- VERV -0.05
- Stochastic Oscillator
- CLFD 64.80
- VERV 4.79
About CLFD Clearfield Inc.
Clearfield Inc mainly designs, manufactures, and distributes fiber protection, fiber management and fiber delivery solutions for communications networks. It provides a range of products including copper assemblies, cassettes, box enclosures, fiber connectors, frames, microduct, terminals, vaults, pedestal inserts, FieldSmart, WaveSmart, and CraftSmart. The company has a global presence with the majority of the revenue derived from the United States. The company has two reportable segments namely Clearfield segment and Nestor cables segment. The majority of revenue is derived from Clearfield segment.
About VERV Verve Therapeutics Inc.
Verve Therapeutics Inc is a genetic medicines company pioneering a new approach to the care of cardiovascular disease, transforming treatment from chronic management to single-course gene editing medicines. The company's initial two programs target PCSK9 and ANGPTL3, genes that have been extensively validated as targets for lowering blood lipids such as low-density lipoprotein cholesterol, a root cause of cardiovascular disease. The company views its operations as and manages its business in one operating segment operating exclusively in the United States.